What we study:
Neural signaling and receptor pharmacology in normal brain functions and neurological and neuropsychiatric diseases.
Our approach:
Both mechanistic signaling studies and preclinical tests using various disease models.
Our goal:
Translate our bench-side research to improved bedside treatment.
